WHO To Start Trials of COVID-19 Vaccine in Nigeria

The World Health Organisation has disclosed that Nigeria has indicated interest in being one of the country’s to receive the COVID-19 trial vaccine currently being developed.

Fiona Braka, Officer in Charge, WHO Nigeria, said this while speaking at the joint national briefing of the Presidential Task Force on COVID-19. She said efforts are currently being made to start the process in the country.

“Nigeria has also expressed interest to be part of this solidarity trial and efforts are underway to start the process in Nigeria too.

“Together with global health actors and partners, over the past week, WHO launched the access to COVID-19 tools ACT accelerator, a global collaboration to accelerate development for equitable access to new COVID-19 diagnostics, therapeutics and vaccines.

At the moment, about 89 vaccines are being developed across the world, with 7 of them already undergoing clinical trials and several other therapeutics are also being tried clinically to fight Coronavirus.

“We have a total of 89 vaccines that are in development globally, including seven in clinical evaluation and several therapeutics are in clinical trials. WHO is committed to ensuring that as medicines and vaccines are developed, they are shared equitably with all countries and people.

“We do have the solidarity trial which is an international clinical trial to help find an effective treatment for COVID-19, launched by the WHO and partners.

Braka also said more than 100 countries have joined the solidarity clinical trial, which was launched by WHO and some partners, to help find an effective treatment for COVID-19.

“More than 100 countries have joined the solidarity trial and to date, over 1,200 patients have been randomized from the first five countries to evaluate the safety and efficacy of full drug and drug combinations.”